Artificial intelligence in psoriasis: Where we are and where we are going

被引:3
|
作者
Liu, Zhenhua [1 ,2 ]
Wang, Xinyu [3 ]
Ma, Yao [4 ]
Lin, Yiting [2 ]
Wang, Gang [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Dermatol, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China
[3] Valdosta State Univ, Dept Econ Finance & Healthcare Adm, Valdosta, GA 31602 USA
[4] Fourth Mil Med Univ, Student Brigade Basic Med Sch, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
artificial intelligence; deep learning; dermatology; machine learning; psoriasis; CONVOLUTIONAL NEURAL-NETWORKS; RISK STRATIFICATION; SEVERITY INDEX; MACHINE VISION; SKIN-CANCER; SEGMENTATION; CLASSIFICATION; MANAGEMENT; ARTHRITIS; IMAGES;
D O I
10.1111/exd.14938
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Artificial intelligence (AI) is a field of computer science that involves the development of programs designed to replicate human cognitive processes and the analysis of complex data. In dermatology, which is predominantly a visual-based diagnostic field, AI has become increasingly important in improving professional processes, particularly in the diagnosis of psoriasis. In this review, we summarized current AI applications in psoriasis: (i) diagnosis, including identification, classification, lesion segmentation, lesion severity and area scoring; (ii) treatment, including prediction treatment efficiency and prediction candidate drugs; (iii) management, including e-health and preventive medicine. Key challenges and future aspects of AI in psoriasis were also discussed, in hope of providing potential directions for future studies.
引用
收藏
页码:1884 / 1899
页数:16
相关论文
共 50 条
  • [21] Artificial Intelligence and IBD: Where are We Now and Where Will We Be in the Future?
    Ahmed M.
    Stone M.L.
    Stidham R.W.
    [J]. Current Gastroenterology Reports, 2024, 26 (5) : 137 - 144
  • [22] Where we come from, where we are, where we are going
    Leonhard, Joachim-Felix
    [J]. INFORMATION-WISSENSCHAFT UND PRAXIS, 2023, 74 (5-6): : 271 - 274
  • [23] Vitamin D analogs in the treatment of psoriasis Where are we standing and where will we be going?
    Tremezaygues, Lea
    Reichrath, Joerg
    [J]. DERMATO-ENDOCRINOLOGY, 2011, 3 (03) : 180 - 186
  • [24] VSP - WHERE WE ARE, WHERE WE ARE GOING
    HARDAGE, BA
    [J]. OIL & GAS JOURNAL, 1988, 86 (12) : 91 - 93
  • [25] AIDS - WHERE ARE WE AND WHERE ARE WE GOING
    GATELL, JM
    [J]. MEDICINA CLINICA, 1992, 98 (20): : 775 - 777
  • [26] The core: Where are we and where are we going?
    Sherry, M
    Best, T
    Heiderscheit, B
    [J]. CLINICAL JOURNAL OF SPORT MEDICINE, 2005, 15 (01): : 1 - 2
  • [27] WHERE ARE WE NOW AND WHERE ARE WE GOING
    KARLAN, BY
    [J]. GYNECOLOGIC ONCOLOGY, 1995, 59 (03) : 315 - 317
  • [28] Where Are We Now and Where Are We Going?
    Sempokuya, Tomoki
    McDonald, Nicholas
    [J]. ACG CASE REPORTS JOURNAL, 2023, 10 (05)
  • [29] Microfinance: where are we and where are we going?
    Nogueira, Serafim
    Duarte, Fabio
    Gama, Ana Paula
    [J]. DEVELOPMENT IN PRACTICE, 2020, 30 (07) : 874 - 889
  • [30] Sarcopenia: Where are we and where are we going?
    Studenski, Stephanie
    [J]. AUSTRALASIAN JOURNAL ON AGEING, 2017, 36 : 14 - 14